---

  - name: James Fickel
    title: Founding Donor and Executive Director
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.

  - name: Joanne Peng
    title: Chief of Staff
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.

  - name: Rohan Krajeski
    title: Consultant, Neuroscience
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.

  - name: Courtney Hudson-Paz
    title: Consultant, Activating Talent
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.

  - name: Raiany Romanni
    title: Consultant, Policy and Ethics
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.

  - name: Martin Borsch Jensen
    title: CSO, Gordian
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.
    advisory_board: true

  - name: Aaron Cravens
    title: CEO, Revel Pharmaceuticals
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.
    advisory_board: true

  - name: Alex Colville
    title: GP, age1
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.
    advisory_board: true

  - name: Laura Deming
    title: CEO, Lorentz
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.
    advisory_board: true

  - name: Kristen Fortney
    title: CEO, BioAge
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.
    advisory_board: true

  - name: Adam Marblestone
    title: CEO, Convergent Research
    image_url: https://cdn.pixabay.com/photo/2016/08/08/09/17/avatar-1577909_960_720.png
    bio: James is an early Ethereum investor and founded Amaranth to accelerate research in longevity. He assembled Amaranth’s SAB, a group of young leaders in longevity biotech, to source and evaluate ambitious research covering brain aging, the aggregome, spinal cord injury, cryopreservation, and neurotech.\n\nHe has backed the Norn Group, Impetus Grants, the SuperAgers Family Initiative, the Longevity Undergraduate Program, MBL Aging Course, as well as labs from Harvard, MIT, and Stanford.
    advisory_board: true
